Clinical Trials Browser

Phase 1 × Neoplasms × B-Cell Activating Factor × Clear all

NCT00024934 2016-09-22

B-Lymphocyte Stimulator (BLyS) To Treat Selective IgA Deficiency

Phase 1 Completed

Immunologic Deficiency Syndromes, Neoplasms, IgA Deficiency